SCHEMBL6832965

SCHEMBL6832965

Cc1cccc(Nc2cc(-c3c[nH]nc3-c3ccccn3)ccn2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNN1 Q92952 1/20 0.44
KCNN2 Q9H2S1 1/20 0.44
KCNN3 Q9UGI6 1/20 0.44
TGFBR1 P36897 7/20 0.43
SLC2A1 P11166 1/20 0.43
NPSR1 Q6W5P4 2/20 0.42
RAB9A P51151 2/20 0.42
CCNB2 O95067 1/20 0.41
CDK1 P06493 1/20 0.41
RET P07949 1/20 0.41
CCNB1 P14635 1/20 0.41
CCNB3 Q8WWL7 1/20 0.41
TNNI3K Q59H18 1/20 0.40
GRM4 Q14833 1/20 0.38
GRM5 P41594 1/20 0.38
KMT2A Q03164 2/20 0.38
MITF O75030 1/20 0.38
GAA P10253 1/20 0.38
HTT P42858 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6829358 0.89 TGFBR1 (0.44) KCNN1KCNN2KCNN3TGFBR1SLC2A1
SCHEMBL6832462 0.87 KDM4E (0.44) KCNN1KCNN2KCNN3TGFBR1NPSR1
SCHEMBL6832969 0.85 GRM4 (0.42) KCNN1KCNN2KCNN3TGFBR1RAB9A
SCHEMBL6834633 0.85 TGFBR1 (0.44) TGFBR1GRM4KMT2APIK3CAMEN1
SCHEMBL6834538 0.83 TGFBR1 (0.47) TGFBR1RAB9AKMT2AHTTSMN1; SMN2
SCHEMBL6832525 0.83 TGFBR1 (0.54) TGFBR1NPSR1RAB9AKMT2AGAA
SCHEMBL6832036 0.83 IGF1R (0.43) TGFBR1GRM5MAPK14
SCHEMBL6832044 0.83 NR4A1 (0.43) TGFBR1RAB9AKMT2AMEN1NPC1
SCHEMBL373075 0.82 TGFBR1 (0.61) TGFBR1GRM5HTTSMN1; SMN2MAPK14
SCHEMBL6834671 0.81 PTGS2 (0.47) TGFBR1TNNI3K

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040097502-A1 Pyrazoles as tgf inhibitors GELLIBERT FRANCOISE JEANNE (FR) 2004-05-20 US claimed
US-20040097502-A1 Pyrazoles as tgf inhibitors GELLIBERT FRANCOISE JEANNE (FR) 2004-05-20 US disclosed
EP-1363904-A1 PYRAZOLES AS TGF INHIBITORS GLAXO GROUP LIMITED (GB) 2003-11-26 EP disclosed
WO-2002062787-A1 PYRAZOLES AS TGF INHIBITORS GLAXO GROUP LIMITED (GB) 2002-08-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040097502-A1 Pyrazoles as tgf inhibitors TGFBR1, TGFBR2, TGFB1 KCNN1 4281/4885KCNN2 4257/4885KCNN3 3331/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.